AMERICAN CENTURY COMPANIES INC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 147 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERICAN CENTURY COMPANIES INC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,142,287
+12.4%
46,153
+28.6%
0.00%0.0%
Q2 2023$1,016,461
+78.5%
35,892
+42.1%
0.00%
Q1 2023$569,590
-1.3%
25,259
+23.0%
0.00%
Q4 2022$576,847
+137.4%
20,543
+139.1%
0.00%
Q3 2022$243,000
-83.9%
8,592
-81.5%
0.00%
-100.0%
Q3 2019$1,506,000
-74.7%
46,472
-61.1%
0.00%
-66.7%
Q2 2019$5,962,000
-20.7%
119,526
+7.2%
0.01%
-25.0%
Q1 2019$7,521,000
+67.5%
111,526
+14.5%
0.01%
+60.0%
Q4 2018$4,490,000
-17.0%
97,366
+16.9%
0.01%
-16.7%
Q4 2015$5,409,000
-56.0%
83,316
-52.2%
0.01%
-60.0%
Q3 2015$12,303,000
-36.5%
174,286
-0.0%
0.02%
-31.8%
Q2 2015$19,371,000
+1909.4%
174,296
+1605.1%
0.02%
+2100.0%
Q1 2015$964,000
-16.4%
10,222
-0.7%
0.00%0.0%
Q4 2014$1,153,000
+100.9%
10,293
+10.1%
0.00%0.0%
Q3 2014$574,0009,3510.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Eagle Health Investments LP 431,413$12,558,0003.09%
Casdin Capital, LLC 2,090,000$60,840,0002.73%
Rock Springs Capital Management LP 2,665,275$77,586,0001.95%
Bellevue Group AG 4,129,292$120,204,0001.40%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,177,374$34,273,0001.05%
Altium Capital Management LP 66,196$1,927,0000.64%
ArrowMark Colorado Holdings LLC 1,295,948$37,725,0000.33%
FARALLON CAPITAL MANAGEMENT LLC 1,333,012$38,804,0000.19%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 21,500$707,0000.16%
Virtus ETF Advisers LLC 11,541$336,0000.15%
View complete list of AGIOS PHARMACEUTICALS INC shareholders